Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2428 studies found for:    OVARIAN CANCER
Show Display Options
Rank Status Study
1 Completed Interactive Educational Website for Women With Ovarian Cancer & Caregivers
Conditions: Stage III Ovarian Cancer;   Stage IV Ovarian Cancer;   Recurrent Ovarian Cancer;   Fallopian Tube Cancer
Interventions: Behavioral: Usual Care Educational Website;   Behavioral: Prototype System
2 Recruiting Pembrolizumab in Combination With Chemotherapy in Frontline Ovarian Cancer
Conditions: Ovarian Cancer;   Metastatic Ovarian Cancer
Interventions: Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Pembrolizumab
3 Terminated Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer
Conditions: Ovarian Cancer;   Epithelial Ovarian Cancer;   Fallopian Tube Carcinoma;   Primary Peritoneal Carcinoma
Interventions: Drug: Lenalidomide, Liposomal Doxorubicin, Bevacizumab;   Drug: Revlimid, Doxil, Avastin
4 Recruiting Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment
Conditions: Recurrent Ovarian Cancer;   Platinum Sensitive Ovarian Cancer
Intervention: Drug: Carboplatin
5 Active, not recruiting Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer
Conditions: Stage III Ovarian Cancer;   Stage IV Ovarian Cancer;   Uterine Cancer
Interventions: Drug: Olaparib;   Drug: Carboplatin;   Drug: Paclitaxel
6 Recruiting Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Conditions: Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer;   Sarcoma;   Uterine Leiomyomata;   Vaginal Cancer;   Vulvar Cancer
Interventions: Other: laboratory biomarker analysis;   Other: screening questionnaire administration;   Procedure: study of high risk factors
7 Recruiting Phase II/III Trial of Maintenance Vigil™ for High Risk Stage III/IV Ovarian Cancer
Conditions: Ovarian Cancer;   Ovarian Neoplasms
Interventions: Biological: Vigil;   Biological: Placebo
8 Completed Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer
Conditions: Ovarian Cancer;   Epithelial Ovarian Cancer
Intervention: Drug: Catumaxomab
9 Completed
Has Results
AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer
Conditions: Ovarian Neoplasms;   Ovarian Cancer
Interventions: Drug: AZD0530;   Drug: Carboplatin;   Drug: Paclitaxel
10 Withdrawn LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma
Conditions: Ovarian Cancer;   Ovarian Carcinoma;   Recurrent Ovarian Cancer;   Recurrent Ovarian Carcinoma
Interventions: Radiation: Low Dose Fractionated Whole Abdominal Radiation Therapy;   Drug: Docetaxel
11 Active, not recruiting A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer
Conditions: Ovarian Cancer;   Malignant Female Reproductive System Neoplasm;   Cancer;   Ovarian Tumor;   Ovarian Epithelial Cancer Recurrent
Interventions: Drug: DOXIL/CAELYX;   Drug: ATI-0918
12 Recruiting Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer
Conditions: Ovarian Cancer;   Ovarian Neoplasms
Interventions: Drug: 18F-EF5 PET/CT scan;   Procedure: Optional biopsy
13 Recruiting PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer
Conditions: Ovarian Neoplasms;   Neoplasms, Ovarian;   Ovarian Cancer
Interventions: Drug: Pazopanib;   Drug: Fosbretabulin
14 Recruiting MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer
Conditions: Cancer of Ovary;   Cancer of the Ovary;   Neoplasms, Ovarian;   Ovarian Cancer;   Ovary Cancer;   Ovary Neoplasms
Interventions: Device: MRI-guided SBRT;   Behavioral: EORTC QLQ-C30 Questionnaire;   Behavioral: EORTC QLQ-OV28 Questionnaire
15 Recruiting Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines
Conditions: Cancer of Ovary;   Cancer of the Ovary;   Neoplasms, Ovarian;   Ovarian Cancer;   Ovary Cancer;   Ovary Neoplasms
Interventions: Biological: Cisplatin + celecoxib + DC vaccine;   Biological: Cisplatin + CKM + Celecoxib + DC Vaccine
16 Recruiting Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer
Conditions: Ovarian Cancer;   Cancer of Ovary;   Cancer of the Ovary;   Ovary Neoplasms;   Primary Peritoneal Carcinoma
Intervention: Drug: Fenretinide/LXS + Ketoconazole
17 Recruiting Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer
Conditions: Low-grade Serous Ovarian Carcinoma;   Recurrent Invasive Borderline Serous Ovarian Cancer
Intervention:
18 Completed Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer Patients
Conditions: Ovarian Cancer;   Healthy Volunteers
Intervention: Drug: Tc 99m EC20
19 Terminated NYU Ovarian Cancer Early Detection Program Blood and Genetics
Condition: Ovarian Cancer
Intervention:
20 Withdrawn Cost Utility Analysis in Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Behavioral: Questionnaire

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years